HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy.
- Resource Type
- Article
- Source
- Journal of International Medical Research; Jan2020, Vol. 48 Issue 1, p1-12, 12p
- Subject
- Language
- ISSN
- 03000605